Crinetics Pharmaceuticals, Inc. Gains 98.74%
Tue, Jul 07, 2026 at 07:46 PM
Crinetics Pharmaceuticals, Inc. (CRNX:NASDAQ) shot up at $83.53, a gain of 98.7%. On Tue, Jul 07, 2026, CRNX:NASDAQ touched a New 2-Week High of $83.53. The stock appeared on our News Catalysts scanner on Tue, Jul 07, 2026 at 01:19 PM in the 'ACQUISITION' category. From Tue, Jun 23, 2026, the stock recorded 77.78% Up Days and 60.00% Green Days
About Crinetics Pharmaceuticals, Inc. (CRNX:NASDAQ)
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 287.5%
- Crinetics Pharmaceuticals, Inc. (CRNX:NASDAQ), 98.74%
- ClearOne, Inc. (CLRO:NASDAQ), 97.71%
- Tvardi Therapeutics, Inc. (TVRD:NASDAQ), 54.23%
- The Beauty Health Company (SKIN:NASDAQ), 47.04%
- Akari Therapeutics, Plc (AKTX:NASDAQ), 42.02%
- Sky Quarry Inc. (SKYQ:NASDAQ), 41.51%
- Trident Digital Tech Holdings Ltd (TDTH:NASDAQ), 40.66%
- Veraxa Biotech AG (VRXA:NASDAQ), 38.36%
- Turn Therapeutics Inc. (TTRX:NASDAQ), 26.27%